Home

BlackRock Portfolio Management reported a 4.7% stake in Stoke Therapeutics STOK · 2,550,341 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
4.7%
Last report
5.1% · filed 25/04/15
Shares held
2,550,341 sh
Class
Common Stock
Event date
25/06/30
Filed
25/07/15

4.7% stake · below 5%

Stake
4.7%
Last report
5.1%
Since last report
−0.4pp

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

BlackRock Portfolio Management's other 5% stake reports

  • BlackRock Portfolio Management

    5% stakeCalamos Global Dynamic Income Fund

    38.6% stake

    Filed 09/08

  • BlackRock Portfolio Management

    5% stakeCalamos Global Total Return Fund

    100% stake

    Filed 09/08

  • BlackRock Portfolio Management

    5% stakeCalamos Convertible Opportunities & Income Fund

    50% stake

    Filed 09/08

  • BlackRock Portfolio Management

    5% stakeCalamos Convertible & High Income Fund

    50% stake

    Filed 09/08

  • BlackRock Portfolio Management

    5% stakeCalamos Strategic Total Return Fund

    36.4% stake

    Filed 09/08